000			01857 a2200541 4500
005			20250515152811.0
264		0	_c20090204
008			200902s 0 0 eng d
022			_a1527-3792
024	7		_a10.1016/j.juro.2008.10.021 _2doi
040			_aNLM _beng _cNLM
100	1		_aLara, Primo N
245	0	0	_aPredictors of survival of advanced renal cell carcinoma: long-term results from Southwest Oncology Group Trial S8949. _h[electronic resource]
260			_bThe Journal of urology _cFeb 2009
300			_a512-6; discussion 516-7 p. _bdigital
500			_aPublication Type: Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAnalysis of Variance
650	0	4	_aBiopsy, Needle
650	0	4	_aCarcinoma, Renal Cell _xmortality
650	0	4	_aCombined Modality Therapy
650	0	4	_aConfidence Intervals
650	0	4	_aFemale
650	0	4	_aFollow-Up Studies
650	0	4	_aHumans
650	0	4	_aImmunohistochemistry
650	0	4	_aInterferons _xtherapeutic use
650	0	4	_aKidney Neoplasms _xmortality
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aMultivariate Analysis
650	0	4	_aNeoplasm Staging
650	0	4	_aNephrectomy _xmethods
650	0	4	_aPredictive Value of Tests
650	0	4	_aProbability
650	0	4	_aProportional Hazards Models
650	0	4	_aRisk Assessment
650	0	4	_aSurvival Analysis
650	0	4	_aTime Factors
650	0	4	_aTreatment Outcome
700	1		_aTangen, Catherine M
700	1		_aConlon, Sarah J
700	1		_aFlanigan, Robert C
700	1		_aCrawford, E David
773	0		_tThe Journal of urology _gvol. 181 _gno. 2 _gp. 512-6; discussion 516-7
856	4	0	_uhttps://doi.org/10.1016/j.juro.2008.10.021 _zAvailable from publisher's website
999			_c18551424 _d18551424